Unaudited Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
REVENUES:
Total revenues	$ 216,530	$ 62,259	$ 465,446	$ 438,210
OPERATING EXPENSES:
Research and development	1,219,144	958,255	3,032,426	1,712,890
General and administrative	1,800,159	3,021,290	5,870,745	8,263,019
TOTAL OPERATING EXPENSES	3,019,303	3,979,545	8,903,171	9,975,909
OPERATING LOSS	(2,802,773)	(3,917,286)	(8,437,725)	(9,537,699)
OTHER INCOME (EXPENSE)
Interest income	77,276	33,600	219,374	48,082
Interest and other expense	(290,773)	(168,272)	(849,457)	(891,835)
Change in fair value of warrant liability	(408,803)	252,458	7,017,923	1,998,878
TOTAL OTHER INCOME (EXPENSE)	(622,300)	117,786	6,387,840	1,155,125
LOSS BEFORE INCOME TAX BENEFIT	(3,425,073)	(3,799,500)	(2,049,885)	(8,382,574)
Income tax benefit				920,000
NET LOSS	$ (3,425,073)	$ (3,799,500)	$ (2,049,885)	$ (7,462,574)
Net loss per common share - basic (in dollars per share)	$ (0.39)	$ (0.44)	$ (0.23)	$ (1.16)
Net loss per common share - diluted (in dollars per share)	$ (0.39)	$ (0.44)	$ (0.23)	$ (1.16)
Weighted average common shares outstanding - basic (in shares)	8,735,790	8,704,985	8,730,303	6,447,053
Weighted average common shares outstanding - diluted (in shares)	8,735,790	8,704,985	8,730,303	6,447,053
Grant [Member]
REVENUES:
Total revenues	$ 216,530	$ 62,259	$ 465,446	$ 438,210